title: Toxic dark effects of protoporphyrin on the cytochrome P-450 system in rat liver microsomes.
abstract: In erythropoietic protoporphyria, accumulation of protoporphyrin has been found in various tissues and liver cirrhosis occurs frequently in this disease, probably due to toxic dark effects of protoporphyrin. We have studied the effect of porphyrins on various enzymic functions in rat liver microsomes. Incubation of microsomes with protoporphyrin resulted in a concentration-dependent inhibition of the oxidation of 7-ethoxycoumarin and aminopyrine by the cytochrome P-450 system. Kinetic analysis showed a decrease in Vmax., whereas the Km was not affected (non-competitive inhibition). Furthermore, reduction of cytochrome c by the NADPH-cytochrome P-450 reductase and by the NADH-cytochrome b5 reductase was inhibited. However, the activity of the reductases was only affected when the microsomes were pre-incubated with protoporphyrin, and it was found that the inhibition was dependent on the duration of the pre-incubation. Kinetic analysis again revealed non-competitive inhibition. When these experiments were repeated with uroporphyrin, no inhibition could be observed. With Stern-Volmer plots it was demonstrated that this was most likely caused by the localization of the porphyrins: protoporphyrin is localized in the membrane, whereas uroporphyrin remains in solution. From these results it is concluded that accumulation of protoporphyrin in the liver may markedly affect the cytochrome P-450 system and thus its detoxification function.
authors.affiliation: Department of Medical Biochemistry, Sylvius Laboratory, Leiden, The Netherlands.
authors.forename: M
authors.initials: M
authors.lastname: Williams
authors.forename: J
authors.initials: J
authors.lastname: Van der Zee
authors.forename: J
authors.initials: J
authors.lastname: Van Steveninck
mesh_terms: D000632:Aminopyrine / Q000378:metabolism; D000818:Animals; D003374:Coumarins / Q000378:metabolism; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003579:Cytochrome Reductases / Q000037:antagonists & inhibitors; D003574:Cytochrome c Group / Q000378:metabolism; D042966:Cytochrome-B(5) Reductase; D005260:Female; D007700:Kinetics; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology*; D009251:NADPH-Ferrihemoprotein Reductase / Q000037:antagonists & inhibitors; D010084:Oxidation-Reduction; D011524:Protoporphyrins / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D003374:Coumarins; D065607:Cytochrome P-450 Enzyme Inhibitors; D003574:Cytochrome c Group; D011524:Protoporphyrins; D000632:Aminopyrine; C017299:7-ethoxycoumarin; D003577:Cytochrome P-450 Enzyme System; D003579:Cytochrome Reductases; D042966:Cytochrome-B(5) Reductase; D009251:NADPH-Ferrihemoprotein Reductase